El programa responsable de vacunar a los pobres del mundo ha estado negociando para tratar de cancelar sus acuerdos con las farmacéuticas por las dosis que ya no necesita, según documentos confidenciales.
As more patients turn to diabetes medications for other uses, a shortage has taken hold. But doctors say going off these drugs can take a toll.
The popular drug discount app deceptively shared details on users’ illnesses and medicines with ad firms, regulators said in a legal complaint.
Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
Hot flashes, sleeplessness, pain during sex: For some of menopause’s worst symptoms, there’s an established treatment. Why aren’t more women offered it?
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
Growing research has shown that intensive interventions are needed, scientists say. Here is why their advice is changing.
New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.
As advisers to the Food and Drug Administration endorsed ending one era of the Covid vaccination campaign, they also grappled with its future.
Las personas que usan medicamentos como Ozempic están encontrando un efecto secundario no deseado: envejecimiento facial.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.